NCT05320068View on ClinicalTrials.gov

Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Clostridioides Difficile Infection
Interventions
DRUG

Oral Vancomycin

A blinded capsule that contains 125mg of vancomycin every 6 hours during 10 days.

DRUG

Placebo

A blinded capsule that contains no vancomycin every 6 hours during 10 days.

Trial Locations (1)

28032

Rafael San Juan, Madrid

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Julia Orígüen

OTHER